Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study
Crossref DOI link: https://doi.org/10.1007/s00592-014-0663-2
Published Online: 2014-10-14
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kim, Seoyoung C.
Glynn, Robert J.
Liu, Jun
Everett, Brendan M.
Goldfine, Allison B.
Text and Data Mining valid from 2014-10-14